PEAK6
TDACW

PEAK6’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

PEAK6’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Buy
+127,163
New +$128K ﹤0.01% 2294

Other funds holding TDACW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

PEAK6's TDACW Position: Q2 2026 in Review

PEAK6 opened a new position in Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026: 127,163 shares worth $181K. The stake represents ﹤0.01% of the portfolio and ranks #2294 among its holdings.

28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • PEAK6 held 127,163 shares of Translational Development Acquisition Corp Warrants worth $181K as of Q2 2026.
  • Translational Development Acquisition Corp Warrants was a new PEAK6 position in Q2 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2294 holding.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.